Publication Archive: Opioids Litigation

Endo Pharmaceuticals has reached a $50 million settlement in the New York Opioid Jury Trial. “This result is a victory for everyone as it ensures resources will be delivered to communities in need without having to deal with the potential for bankruptcy proceedings,” Counsel for Nassau County said Partner Hunter Shkolnik. Download Read the article

Arnold & Porter Kaye Scholer, facing civil contempt allegations related to the New York opioid litigation, is in hot water in a case that highlights the increasingly high stakes for law firms handling voluminous discovery. Senior enforcement counsel in the AG’s office, and Napoli Shkolnik have argued it was impossible to know what the result…Read the article

In a statement, Paul Napoli of Napoli Shkolnik said the Arnold & Porter attorneys who worked on the case “should be disciplined by the Court and the bar.” Suffolk County Supreme Court Justice Jerry Garguilo scheduled a hearing for attorneys from defense counsel and their client, Endo Pharmaceuticals, to explain why he should not hold…Read the article

Thursday’s testimony came from Angela Feniger, Par’s former DEA compliance director, who is now an associate director of technical writing and quality assurance at the drugmaker. In 2010, she testified that Par hired outside consultants to conduct an internal audit of the company’s compliance with the agency processes. “And the point of the audit was…Read the article

The New York judge overseeing the state’s trial over the opioid crisis on Monday ordered Endo Pharmaceuticals and its firm Arnold & Porter to explain discovery violations and why Endo shouldn’t be hit with a default judgment for its liability for the epidemic, following accusations of discovery cover-up in separate cases. “The depth of the deceit…Read the article

The New York attorney general and six other state attorneys general on Wednesday formally announced a global opioid settlement worth $26 billion with Johnson & Johnson and the nation’s three largest drug distributors. A trial over the New York state and two Long Island counties’ opioid suit (Nassau County is a client of Napoli Shkolnik)…Read the article

The three largest drug distributors, McKesson Corp, Cardinal Health Inc, and AmerisourceBergen Corp, will dole out at least $86 million to each county over 18 years, which officials said would go straight toward drug treatment and prevention. Napoli Shkolnik client Nassau will also be one of 17 members of the National Enforcement Committee, which is…Read the article

The legislatures of Nassau County and Suffolk County will have the opportunity to formally approve Tuesday’s settlement in August. The agreement would send $86 million to Nassau County and $106 million to Suffolk County. Paul Napoli of Napoli Shkolnik, who represents Nassau County, said that the New York settlement is “the impetus and the driving…Read the article

As part of an upcoming nationwide settlement, the nation’s three largest drug distributors on Tuesday struck a $1.1 billion opioid deal with New York’s attorney general and exited a closely watched jury trial. “Unlike the national deal, it is not contingent on the rest of the country or other states joining,” Hunter Shkolnik of Napoli…Read the article

On Long Island, the settlement with McKesson, Amerisource Bergen and CardinalHealth means Nassau County will receive nearly $87 million; Suffolk County between $87 million and $106 million. The agreement will remove the companies from an ongoing opioid trial underway in a state court in Suffolk County. DownloadRead the article